chr11-63370394-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_080866.3(SLC22A9):āc.338T>Cā(p.Met113Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,612,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M113L) has been classified as Uncertain significance.
Frequency
Consequence
NM_080866.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC22A9 | NM_080866.3 | c.338T>C | p.Met113Thr | missense_variant | 1/10 | ENST00000279178.4 | |
SLC22A9 | XM_017017159.3 | c.338T>C | p.Met113Thr | missense_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC22A9 | ENST00000279178.4 | c.338T>C | p.Met113Thr | missense_variant | 1/10 | 1 | NM_080866.3 | P1 | |
SLC22A9 | ENST00000536333.5 | c.338T>C | p.Met113Thr | missense_variant, NMD_transcript_variant | 1/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 250174Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135188
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460782Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 726682
GnomAD4 genome AF: 0.000177 AC: 27AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74338
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 12, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at